New pill aims to break the cycle of repeat c. diff infections
Disease control
Recruiting now
This phase 2 trial tests an oral drug called ibezapolstat in 20 people who have had three or more C. diff infections in the past year. The goal is to see if the drug can cure the current infection and reduce the chance of it coming back. Participants will take the drug twice a da…
Phase 2 • Sponsor: Acurx Pharmaceuticals Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC